Inflammatory breast cancer is a rare, very aggressive cancer that accounts for up to 5% of all breast cancers in the US1. At the time of diagnosis, inflammatory breast cancer is usually stage III or IV1. As many as 30% of cases involve metastasis2. Identifying inflammatory breast cancer can be challenging because symptoms emerge rapidly and may be mistaken for an acute inflammatory process like mastitis3. It is more common among African American women, women under 40, and women who are overweight or obese2. As a result of lymphatic fluid buildup within the breast, clinical manifestations include bruising or redness, swelling, warmth, pain, itching, dimpling of the skin, or pulling of the nipple1-3. Traditional mammography may not be useful in diagnosing inflammatory breast cancer. Most women with inflammatory breast cancer do not have a lump and their breast tissue is dense1. These factors make mammography less definitive, but it can be useful in identifying lymph node involvement. An ultrasound, PET scan, CT scan, or bone scan can also be used to evaluate metastasis1. A breast biopsy is used to definitively diagnose inflammatory breast cancer1-3. The standard of care for nonmetastatic inflammatory breast cancer employs a trimodal approach of systemic chemotherapy followed by modified radical mastectomy and radiation1-3. The survival rate for women with inflammatory breast cancer is lower than that of women with other types of breast cancer1-4. But outcomes associated with this trimodal approach have favorable control rates4, which highlights the importance of early detection and prompt treatment of inflammatory breast cancer. Let’s use breast cancer awareness month as an opportunity to educate our patients about inflammatory breast cancer.
Hester, R. H., Hortobagyi, G. N., Lim, B. (2021). Inflammatory breast cancer: Early recognition and diagnosis is critical. American Journal of Obstetrics & Gynecology, 4, 392-396. DOI: https://doi.org/10.1016/j.ajog.2021.04.217
Inflammatory Breast Cancer
Inflammatory Breast Cancer
By: Mona Williams-Gregory, PhD, DNP, APRN
Inflammatory breast cancer is a rare, very aggressive cancer that accounts for up to 5% of all breast cancers in the US1. At the time of diagnosis, inflammatory breast cancer is usually stage III or IV1. As many as 30% of cases involve metastasis2. Identifying inflammatory breast cancer can be challenging because symptoms emerge rapidly and may be mistaken for an acute inflammatory process like mastitis3. It is more common among African American women, women under 40, and women who are overweight or obese2. As a result of lymphatic fluid buildup within the breast, clinical manifestations include bruising or redness, swelling, warmth, pain, itching, dimpling of the skin, or pulling of the nipple1-3. Traditional mammography may not be useful in diagnosing inflammatory breast cancer. Most women with inflammatory breast cancer do not have a lump and their breast tissue is dense1. These factors make mammography less definitive, but it can be useful in identifying lymph node involvement. An ultrasound, PET scan, CT scan, or bone scan can also be used to evaluate metastasis1. A breast biopsy is used to definitively diagnose inflammatory breast cancer1-3. The standard of care for nonmetastatic inflammatory breast cancer employs a trimodal approach of systemic chemotherapy followed by modified radical mastectomy and radiation1-3. The survival rate for women with inflammatory breast cancer is lower than that of women with other types of breast cancer1-4. But outcomes associated with this trimodal approach have favorable control rates4, which highlights the importance of early detection and prompt treatment of inflammatory breast cancer. Let’s use breast cancer awareness month as an opportunity to educate our patients about inflammatory breast cancer.
References
Related Posts
NPACE Notes: November 2022
Table of Content 1. From the Director 2. 2023 Conferences 3. Black Friday Sale 4. Partners of NPACE 5. Monthly …
The Vaping Crisis – Updates in EVALI
Takeaways While there is still lacking research, the adverse effects of using e-cigarettes include more than just the risks of …
Traumatic Brain Injuries: Increasing Awareness
By: Amy Bruno, Ph.D., ANP-BC March is “Brain Injury Awareness Month” and as we spring ahead towards warmer weather, let …